GLP-1 Drugs Halve Cardiac Risk

Recent research showed that GLP-1 receptor agonists reduce cardiac event risks by half in certain patient groups. This finding supports expanded use of these drugs beyond diabetes management. The study contributes to ongoing discussions in cardiovascular medicine.

PCI volumes in US hospitals declined in 2022

4 октября 2025 Сообщено ИИ

After a surge during the COVID-19 pandemic, percutaneous coronary intervention (PCI) procedure volumes in U.S. hospitals dropped by about 5% in 2022 compared to the previous year. Data from the American College of Cardiology's CathPCI Registry highlights this trend, reflecting ongoing recovery challenges in cardiology care. Experts attribute the decline to lingering effects of the pandemic on patient volumes and procedural backlogs.

Baxdrostat Effective for Hypertension

A new study revealed that Baxdrostat significantly reduces blood pressure in patients with resistant hypertension. The findings challenge existing treatments and suggest a new option for managing this condition. Results were highlighted as part of recent medical advancements.

Clopidogrel Versus Aspirin Study Released

11 сентября 2025 Сообщено ИИ

A new study questions the standard use of aspirin by comparing it to clopidogrel in certain medical contexts. The research suggests potential shifts in treatment protocols based on outcomes. This was highlighted as part of recent medical advancements.